GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (NSE:JUBLPHARMA) » Definitions » Shiller PE Ratio

Jubilant Pharmova (NSE:JUBLPHARMA) Shiller PE Ratio : 25.13 (As of May. 23, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Jubilant Pharmova Shiller PE Ratio?

As of today (2025-05-23), Jubilant Pharmova's current share price is ₹1069.15. Jubilant Pharmova's E10 for the quarter that ended in Mar. 2025 was ₹42.55. Jubilant Pharmova's Shiller PE Ratio for today is 25.13.

The historical rank and industry rank for Jubilant Pharmova's Shiller PE Ratio or its related term are showing as below:

NSE:JUBLPHARMA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.79   Med: 21.45   Max: 45.53
Current: 23.42

During the past years, Jubilant Pharmova's highest Shiller PE Ratio was 45.53. The lowest was 7.79. And the median was 21.45.

NSE:JUBLPHARMA's Shiller PE Ratio is ranked better than
53.23% of 526 companies
in the Drug Manufacturers industry
Industry Median: 25.21 vs NSE:JUBLPHARMA: 23.42

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jubilant Pharmova's adjusted earnings per share data for the three months ended in Mar. 2025 was ₹9.680. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹42.55 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Jubilant Pharmova Shiller PE Ratio Historical Data

The historical data trend for Jubilant Pharmova's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Shiller PE Ratio Chart

Jubilant Pharmova Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.57 15.00 7.79 15.49 21.06

Jubilant Pharmova Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.49 18.92 27.96 26.26 21.06

Competitive Comparison of Jubilant Pharmova's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Pharmova's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jubilant Pharmova's Shiller PE Ratio falls into.


;
;

Jubilant Pharmova Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jubilant Pharmova's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1069.15/42.55
=25.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jubilant Pharmova's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Jubilant Pharmova's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=9.68/157.5517*157.5517
=9.680

Current CPI (Mar. 2025) = 157.5517.

Jubilant Pharmova Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 8.280 99.841 13.066
201509 8.100 101.753 12.542
201512 7.890 102.901 12.080
201603 0.720 102.518 1.107
201606 9.630 105.961 14.319
201609 9.290 105.961 13.813
201612 7.660 105.196 11.472
201703 9.630 105.196 14.423
201706 9.940 107.109 14.621
201709 8.230 109.021 11.894
201712 13.640 109.404 19.643
201803 9.940 109.786 14.265
201806 13.000 111.317 18.400
201809 13.500 115.142 18.472
201812 16.740 115.142 22.906
201903 -6.380 118.202 -8.504
201906 11.610 120.880 15.132
201909 15.660 123.175 20.031
201912 12.770 126.235 15.938
202003 16.350 124.705 20.656
202006 5.530 127.000 6.860
202009 14.060 130.118 17.024
202012 19.460 130.889 23.424
202103 13.430 131.771 16.058
202106 10.090 134.084 11.856
202109 8.970 135.847 10.403
202112 3.200 138.161 3.649
202203 3.740 138.822 4.245
202206 2.960 142.347 3.276
202209 0.340 144.661 0.370
202212 -0.980 145.763 -1.059
202303 -6.150 146.865 -6.598
202306 0.400 150.280 0.419
202309 3.940 151.492 4.098
202312 4.200 152.924 4.327
202403 -3.690 153.035 -3.799
202406 30.350 155.789 30.693
202409 6.460 157.882 6.446
202412 6.360 158.323 6.329
202503 9.680 157.552 9.680

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jubilant Pharmova  (NSE:JUBLPHARMA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Jubilant Pharmova Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jubilant Pharmova Business Description

Traded in Other Exchanges
Address
1A, Sector 16A, Noida, UP, IND, 201301
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.

Jubilant Pharmova Headlines

No Headlines